Live price temporarily unavailable.
Marpai (MRAI) is a Health Care company. Latest news and coverage below.
| FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | — | $14.2M | $24.3M | $37.2M | $28.2M | $18.1M |
| Growth (year over year) | — | — | +71.1% | +52.6% | −24.2% | −35.8% |
| Gross profit | — | $3.94M | $7.21M | $12.9M | $9.11M | $4.78M |
| Gross margin | — | 27.7% | 29.6% | 34.8% | 32.3% | 26.4% |
| Operating income | −$3.37M | −$15.9M | −$27.0M | −$28.0M | −$22.1M | −$13.6M |
| Operating margin | — | −111.5% | −110.7% | −75.3% | −78.4% | −74.9% |
| Net income | −$3.87M | −$16.0M | −$26.5M | −$28.8M | −$22.1M | −$16.6M |
| Net margin | — | −112.4% | −108.7% | −77.4% | −78.4% | −91.5% |
| EPS (diluted) | −$6.40 | −$6.36 | −$5.23 | −$4.14 | −$1.92 | −$0.95 |
| Balance sheet | ||||||
| Cash and equivalents | $1.75M | $19.2M | $13.8M | $1.15M | $764.0K | $133.0K |
| Total assets | $6.53M | $44.2M | $49.9M | $31.7M | $12.9M | $10.9M |
| Total liabilities | $10.0M | $14.5M | $43.8M | $45.1M | $40.6M | $43.5M |
| Long-term debt | — | $0 | $20.2M | $19.4M | $17.8M | $11.4M |
| Shareholders' equity | −$3.50M | $29.7M | $6.13M | −$13.4M | −$27.7M | −$32.6M |
| Cash flow | ||||||
| Operating cash flow | −$1.95M | −$10.8M | −$35.2M | −$15.7M | −$15.2M | −$7.45M |
| Capital expenditure | $30.7K | $273.4K | $362.8K | — | — | — |
| Free cash flow | −$1.98M | −$11.1M | −$35.6M | — | — | — |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $7.01M | $6.59M | $5.42M | $4.66M | $4.04M | $3.99M | $4.44M | $4.17M |
| Growth (year over year) | −19.7% | −24.3% | −26.6% | −35.2% | −42.4% | −39.5% | −18.0% | −10.5% |
| Gross profit | $1.98M | $2.60M | $1.93M | $746.0K | $1.07M | $1.03M | $1.21M | $997.0K |
| Gross margin | 28.2% | 39.5% | 35.7% | 16.0% | 26.6% | 25.7% | 27.1% | 23.9% |
| Operating income | −$3.06M | −$2.69M | −$2.25M | −$3.61M | −$2.77M | −$4.92M | −$2.48M | −$3.43M |
| Operating margin | −43.7% | −40.8% | −41.5% | −77.5% | −68.6% | −123.5% | −55.9% | −82.4% |
| Net income | −$3.56M | −$1.16M | −$3.07M | −$4.37M | −$3.49M | −$5.63M | −$3.18M | −$4.58M |
| Net margin | −50.8% | −17.5% | −56.6% | −93.9% | −86.5% | −141.1% | −71.6% | −110.0% |
| EPS (diluted) | −$0.30 | $0.07 | −$0.21 | −$0.28 | −$0.20 | −$0.26 | −$0.13 | −$0.18 |
| Balance sheet | ||||||||
| Cash and equivalents | $830.0K | $764.0K | $729.0K | $619.0K | $445.0K | $133.0K | $201.0K | $138.0K |
| Total assets | $19.6M | $12.9M | $13.7M | $11.1M | $12.8M | $10.9M | $10.9M | $9.47M |
| Total liabilities | $47.2M | $40.6M | $43.9M | $43.4M | $46.1M | $43.5M | $46.2M | $48.4M |
| Long-term debt | $24.5M | $17.8M | $15.2M | $15.7M | $16.1M | $11.4M | $11.9M | $18.3M |
| Shareholders' equity | −$27.6M | −$27.7M | −$30.2M | −$32.4M | −$33.3M | −$32.6M | −$35.2M | −$38.9M |
| Cash flow | ||||||||
| Operating cash flow | −$3.77M | −$4.68M | −$115.0K | −$3.21M | $634.0K | −$4.76M | −$477.0K | −$4.10M |
From Marpai's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning Marpai in our feed yet.